Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.100
-0.020 (-0.94%)
Aug 6, 2026, 11:19 AM EDT - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $364.52 million as of August 6, 2026. Its market cap has increased by 7,351.97% in one year.
Market Cap
364.52M
Enterprise Value
235.36M
1-Year Change
7,351.97%
Ranking
Category
Stock Price
$2.10
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $364.52M, an increase of 385.58%. That is a compound annual growth rate of 34.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 364.52M | 4.10% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 357.10M |
| DiaMedica Therapeutics | 351.32M |
| Agenus | 349.96M |
| Upstream Bio | 349.38M |
| Compass Therapeutics | 339.47M |
| Fennec Pharmaceuticals | 333.13M |
| Zentalis Pharmaceuticals | 331.02M |
| Lexeo Therapeutics | 329.79M |